Artal Group’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-203,000	Closed	-$8.5M	–	47
2024 Q2	$8.5M	Buy	203,000 +153,000	+306%	+$6.41M	0.22%	42
2024 Q1	$1.88M	Buy	+50,000	New	+$1.88M	0.05%	79